These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

111 related items for PubMed ID: 14675943

  • 1. Interactions of the dimeric triad of HIV-1 aspartyl protease with inhibitors.
    Mager PP, De Clercq E, Froeyen M, Reinhardt R.
    Drug Des Discov; 2003; 18(2-3):53-64. PubMed ID: 14675943
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Structural analysis of lead fullerene-based inhibitor bound to human immunodeficiency virus type 1 protease in solution from molecular dynamics simulations.
    Lee VS, Nimmanpipug P, Aruksakunwong O, Promsri S, Sompornpisut P, Hannongbua S.
    J Mol Graph Model; 2007 Sep; 26(2):558-70. PubMed ID: 17468026
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Molecular dynamics simulations of the three dimensional model of plasmepsin II-peptidic inhibitor complexes.
    Pranav Kumar SK, Kulkarni VM.
    Drug Des Discov; 2001 Sep; 17(4):293-313. PubMed ID: 11765133
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Binding of phosphinate and phosphonate inhibitors to aspartic proteases: a first-principles study.
    Vidossich P, Carloni P.
    J Phys Chem B; 2006 Jan 26; 110(3):1437-42. PubMed ID: 16471695
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Unexpected novel binding mode of pyrrolidine-based aspartyl protease inhibitors: design, synthesis and crystal structure in complex with HIV protease.
    Specker E, Böttcher J, Brass S, Heine A, Lilie H, Schoop A, Müller G, Griebenow N, Klebe G.
    ChemMedChem; 2006 Jan 26; 1(1):106-17. PubMed ID: 16892342
    [Abstract] [Full Text] [Related]

  • 18. Ddi1, a eukaryotic protein with the retroviral protease fold.
    Sirkis R, Gerst JE, Fass D.
    J Mol Biol; 2006 Dec 01; 364(3):376-87. PubMed ID: 17010377
    [Abstract] [Full Text] [Related]

  • 19. Pentacycloundecane-diol-based HIV-1 protease inhibitors: biological screening, 2D NMR, and molecular simulation studies.
    Honarparvar B, Makatini MM, Pawar SA, Petzold K, Soliman ME, Arvidsson PI, Sayed Y, Govender T, Maguire GE, Kruger HG.
    ChemMedChem; 2012 Jun 01; 7(6):1009-19. PubMed ID: 22544389
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.